Altimmune Inc [ALT] stock is trading at $8.79, down -0.68%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The ALT shares have gain 2.57% over the last week, with a monthly amount glided 30.42%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Altimmune Inc [NASDAQ: ALT] stock has seen the most recent analyst activity on November 12, 2024, when UBS initiated its Buy rating and assigned the stock a price target of $26. Previously, Guggenheim downgraded its rating to Neutral on April 29, 2024. On January 24, 2024, Goldman initiated with a Neutral rating and assigned a price target of $13 on the stock. Goldman downgraded its rating to a Neutral and decreased its price target to $6 on March 22, 2023. Goldman initiated its recommendation with a Buy and recommended $20 as its price target on December 01, 2022. In a note dated June 02, 2021, H.C. Wainwright initiated an Buy rating and provided a target price of $35 on this stock.
Altimmune Inc [ALT] stock has fluctuated between $4.06 and $14.84 over the past year. Currently, Wall Street analysts expect the stock to reach $23.6 within the next 12 months. Altimmune Inc [NASDAQ: ALT] shares were valued at $8.79 at the most recent close of the market. An investor can expect a potential return of 168.49% based on the average ALT price forecast.
Analyzing the ALT fundamentals
Altimmune Inc [NASDAQ:ALT] reported sales of 0.05M for the trailing twelve months, which represents a drop of -98.62%. Gross Profit Margin for this corporation currently stands at -38.58% with Operating Profit Margin at -1913.65%, Pretax Profit Margin comes in at -1990.77%, and Net Profit Margin reading is -1990.77%. To continue investigating profitability, this company’s Return on Assets is posted at -0.7, Equity is -0.63 and Total Capital is -0.71.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 8.46 points at the first support level, and at 8.12 for the second support level. However, for the 1st resistance point, the stock is sitting at 9.31, and for the 2nd resistance point, it is at 9.82.
Ratios To Look Out For
For context, Altimmune Inc’s Current Ratio is 16.87. Further, the Quick Ratio stands at 16.87, while the Cash Ratio is 3.64. Considering the valuation of this stock, the price to sales ratio is 12503.65, the price to book ratio is 4.69.
Transactions by insiders
Recent insider trading involved Drutz David, Director, that happened on Aug 19 ’24 when 16011.0 shares were sold.
